Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:08:14 UTC |
---|
Update Date | 2019-07-23 07:15:25 UTC |
---|
HMDB ID | HMDB0060935 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 4-trans-Hydroxyglipizide |
---|
Description | 4-trans-Hydroxyglipizide is a metabolite of glipizide. Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas. Mechanism of action is produced by blocking potassium channels in the beta cells of the islets of Langerhans. (Wikipedia) |
---|
Structure | CC1=CN=C(C=N1)C(O)=NCCC1=CC=C(C=C1)S(=O)(=O)NC(O)=N[C@H]1CC[C@H](O)CC1 InChI=1S/C21H27N5O5S/c1-14-12-24-19(13-23-14)20(28)22-11-10-15-2-8-18(9-3-15)32(30,31)26-21(29)25-16-4-6-17(27)7-5-16/h2-3,8-9,12-13,16-17,27H,4-7,10-11H2,1H3,(H,22,28)(H2,25,26,29)/t16-,17- |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H27N5O5S |
---|
Average Molecular Weight | 461.535 |
---|
Monoisotopic Molecular Weight | 461.173289689 |
---|
IUPAC Name | 5-methyl-N-(2-{4-[({[(1r,4r)-4-hydroxycyclohexyl]-C-hydroxycarbonimidoyl}amino)sulfonyl]phenyl}ethyl)pyrazine-2-carboximidic acid |
---|
Traditional Name | 5-methyl-N-{2-[4-({[(1r,4r)-4-hydroxycyclohexyl]-C-hydroxycarbonimidoyl}aminosulfonyl)phenyl]ethyl}pyrazine-2-carboximidic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=CN=C(C=N1)C(O)=NCCC1=CC=C(C=C1)S(=O)(=O)NC(O)=N[C@H]1CC[C@H](O)CC1 |
---|
InChI Identifier | InChI=1S/C21H27N5O5S/c1-14-12-24-19(13-23-14)20(28)22-11-10-15-2-8-18(9-3-15)32(30,31)26-21(29)25-16-4-6-17(27)7-5-16/h2-3,8-9,12-13,16-17,27H,4-7,10-11H2,1H3,(H,22,28)(H2,25,26,29)/t16-,17- |
---|
InChI Key | WPQWQJBFAJEUHS-QAQDUYKDSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzenesulfonamides |
---|
Direct Parent | Benzenesulfonamides |
---|
Alternative Parents | |
---|
Substituents | - Benzenesulfonamide
- Benzenesulfonyl group
- Cyclohexanol
- Sulfonylurea
- Pyrazine
- Cyclic alcohol
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Aminosulfonyl compound
- Heteroaromatic compound
- Secondary alcohol
- Carboximidic acid derivative
- Azacycle
- Carboximidic acid
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Hydrocarbon derivative
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic nitrogen compound
- Organic oxide
- Alcohol
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4-trans-Hydroxyglipizide,1TMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)NC(O)=N[C@H]3CC[C@H](O)CC3)C=C2)O[Si](C)(C)C)C=N1 | 4183.1 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,1TMS,isomer #2 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(=N[C@H]3CC[C@H](O)CC3)O[Si](C)(C)C)C=C2)C=N1 | 4230.9 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,1TMS,isomer #3 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)C=C2)C=N1 | 4263.4 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,1TMS,isomer #4 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)N(C(O)=N[C@H]3CC[C@H](O)CC3)[Si](C)(C)C)C=C2)C=N1 | 4237.2 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)NC(=N[C@H]3CC[C@H](O)CC3)O[Si](C)(C)C)C=C2)O[Si](C)(C)C)C=N1 | 4065.0 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TMS,isomer #2 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)NC(O)=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)C=C2)O[Si](C)(C)C)C=N1 | 4050.2 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TMS,isomer #3 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(O)=N[C@H]3CC[C@H](O)CC3)[Si](C)(C)C)C=C2)O[Si](C)(C)C)C=N1 | 4033.9 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TMS,isomer #4 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)O[Si](C)(C)C)C=C2)C=N1 | 4080.5 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TMS,isomer #5 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O)CC3)O[Si](C)(C)C)[Si](C)(C)C)C=C2)C=N1 | 4063.3 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TMS,isomer #6 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)N(C(O)=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)[Si](C)(C)C)C=C2)C=N1 | 4063.2 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,3TMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)NC(=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)O[Si](C)(C)C)C=C2)O[Si](C)(C)C)C=N1 | 3909.9 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,3TMS,isomer #2 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O)CC3)O[Si](C)(C)C)[Si](C)(C)C)C=C2)O[Si](C)(C)C)C=N1 | 3924.3 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,3TMS,isomer #3 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(O)=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)[Si](C)(C)C)C=C2)O[Si](C)(C)C)C=N1 | 3918.9 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,3TMS,isomer #4 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)O[Si](C)(C)C)[Si](C)(C)C)C=C2)C=N1 | 3942.1 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,4TMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)O[Si](C)(C)C)[Si](C)(C)C)C=C2)O[Si](C)(C)C)C=N1 | 3835.2 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,4TMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)O[Si](C)(C)C)[Si](C)(C)C)C=C2)O[Si](C)(C)C)C=N1 | 3536.8 | Standard non polar | 33892256 | 4-trans-Hydroxyglipizide,4TMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O[Si](C)(C)C)CC3)O[Si](C)(C)C)[Si](C)(C)C)C=C2)O[Si](C)(C)C)C=N1 | 5393.4 | Standard polar | 33892256 | 4-trans-Hydroxyglipizide,1TBDMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)NC(O)=N[C@H]3CC[C@H](O)CC3)C=C2)O[Si](C)(C)C(C)(C)C)C=N1 | 4394.9 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,1TBDMS,isomer #2 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(=N[C@H]3CC[C@H](O)CC3)O[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4443.6 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,1TBDMS,isomer #3 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=N[C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)C=C2)C=N1 | 4464.3 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,1TBDMS,isomer #4 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)N(C(O)=N[C@H]3CC[C@H](O)CC3)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4478.4 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TBDMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)NC(=N[C@H]3CC[C@H](O)CC3)O[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)C=N1 | 4442.2 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TBDMS,isomer #2 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)NC(O)=N[C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)C=C2)O[Si](C)(C)C(C)(C)C)C=N1 | 4447.7 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TBDMS,isomer #3 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(O)=N[C@H]3CC[C@H](O)CC3)[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)C=N1 | 4476.2 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TBDMS,isomer #4 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(=N[C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)O[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4486.4 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TBDMS,isomer #5 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O)CC3)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4490.2 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,2TBDMS,isomer #6 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)N(C(O)=N[C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4518.3 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,3TBDMS,isomer #1 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)NC(=N[C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)O[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)C=N1 | 4484.8 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,3TBDMS,isomer #2 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O)CC3)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)C=N1 | 4534.3 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,3TBDMS,isomer #3 | CC1=CN=C(C(=NCCC2=CC=C(S(=O)(=O)N(C(O)=N[C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)[Si](C)(C)C(C)(C)C)C=C2)O[Si](C)(C)C(C)(C)C)C=N1 | 4535.2 | Semi standard non polar | 33892256 | 4-trans-Hydroxyglipizide,3TBDMS,isomer #4 | CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)N(C(=N[C@H]3CC[C@H](O[Si](C)(C)C(C)(C)C)CC3)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)C=N1 | 4561.1 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 4-trans-Hydroxyglipizide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0w93-8926500000-b1f77e53010b280710f4 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-trans-Hydroxyglipizide GC-MS (3 TMS) - 70eV, Positive | splash10-03k9-4523429000-e0ccdaeb3933e5beef25 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4-trans-Hydroxyglipizide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 10V, Positive-QTOF | splash10-0006-2209600000-5aad21e860dae640443c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 20V, Positive-QTOF | splash10-01oy-6904000000-afb161cdc06418ce541d | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 40V, Positive-QTOF | splash10-01ox-8901000000-4c0c19b86495d3dbc461 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 10V, Negative-QTOF | splash10-03di-1407900000-992c1bfeea2fffc14ebd | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 20V, Negative-QTOF | splash10-014j-2519000000-308dc505af787a161469 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 40V, Negative-QTOF | splash10-0006-9811000000-3e4f38aa86f3824ab46e | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 10V, Positive-QTOF | splash10-03kc-0107900000-534290476e68fa276b79 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 20V, Positive-QTOF | splash10-0fka-2029100000-bf98f87b992ea0f4ba24 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 40V, Positive-QTOF | splash10-0uy0-3942400000-4da75943aeed88982766 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 10V, Negative-QTOF | splash10-03di-0001900000-c8058b5ba03368bd726b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 20V, Negative-QTOF | splash10-0gbc-3109200000-b70eb8ff8b96d3ab6db0 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-trans-Hydroxyglipizide 40V, Negative-QTOF | splash10-0006-9122100000-61c5cc91de063377e3c0 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|